C149H146ClF4N33O6 — CID 157187525
[6-[5-chloro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[5-fluoro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-3-[(2R)-2-(4-methylphenyl)propyl]pyridazine-4-carbonitrile;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-1,6-dimethylindole;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-6-methyl-1H-indole;[3-(4-methylimidazol-1-yl)-6-[6-[(2R)-2-(4-methylphenyl)propyl]-5-(trifluoromethyl)pyridazin-3-yl]-2-pyridinyl]methanol (PubChem CID 157187525) has the molecular formula C149H146ClF4N33O6 and a molecular weight of 2606.48 g/mol. Its IUPAC name is [6-[5-chloro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[5-fluoro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-3-[(2R)-2-(4-methylphenyl)propyl]pyridazine-4-carbonitrile;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-1,6-dimethylindole;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-6-methyl-1H-indole;[3-(4-methylimidazol-1-yl)-6-[6-[(2R)-2-(4-methylphenyl)propyl]-5-(trifluoromethyl)pyridazin-3-yl]-2-pyridinyl]methanol.
| Compound Name | [6-[5-chloro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[5-fluoro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-3-[(2R)-2-(4-methylphenyl)propyl]pyridazine-4-carbonitrile;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-1,6-dimethylindole;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-6-methyl-1H-indole;[3-(4-methylimidazol-1-yl)-6-[6-[(2R)-2-(4-methylphenyl)propyl]-5-(trifluoromethyl)pyridazin-3-yl]-2-pyridinyl]methanol |
|---|---|
| PubChem CID | 157187525 |
| Molecular Formula | C149H146ClF4N33O6 |
| Molecular Weight | 2606.48 g/mol |
| Exact Mass | 2604.18 |
| IUPAC Name | [6-[5-chloro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;[6-[5-fluoro-6-[(2R)-2-(4-methylphenyl)propyl]pyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-3-[(2R)-2-(4-methylphenyl)propyl]pyridazine-4-carbonitrile;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-1,6-dimethylindole;3-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]methyl]-6-methyl-1H-indole;[3-(4-methylimidazol-1-yl)-6-[6-[(2R)-2-(4-methylphenyl)propyl]-5-(trifluoromethyl)pyridazin-3-yl]-2-pyridinyl]methanol |
| SMILES | COc1nc(-c2cc(C)c(Cc3c[nH]c4cc(C)ccc34)nn2)ccc1-n1cnc(C)c1.COc1nc(-c2cc(C)c(Cc3cn(C)c4cc(C)ccc34)nn2)ccc1-n1cnc(C)c1.Cc1ccc([C@H](C)Cc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2C#N)cc1.Cc1ccc([C@H](C)Cc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2C(F)(F)F)cc1.Cc1ccc([C@H](C)Cc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2Cl)cc1.Cc1ccc([C@H](C)Cc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2F)cc1 |
| InChI | InChI=1S/C26H26N6O.C25H24F3N5O.2C25H24N6O.C24H24ClN5O.C24H24FN5O/c1-16-6-7-20-19(14-31(4)25(20)10-16)12-22-17(2)11-23(30-29-22)21-8-9-24(26(28-21)33-5)32-13-18(3)27-15-32;1-15-4-6-18(7-5-15)16(2)10-21-19(25(26,27)28)11-22(32-31-21)20-8-9-24(23(13-34)30-20)33-12-17(3)29-14-33;1-15-5-6-19-18(12-26-22(19)9-15)11-21-16(2)10-23(30-29-21)20-7-8-24(25(28-20)32-4)31-13-17(3)27-14-31;1-16-4-6-19(7-5-16)17(2)10-22-20(12-26)11-23(30-29-22)21-8-9-25(24(14-32)28-21)31-13-18(3)27-15-31;2*1-15-4-6-18(7-5-15)16(2)10-21-19(25)11-22(29-28-21)20-8-9-24(23(13-31)27-20)30-12-17(3)26-14-30/h6-11,13-15H,12H2,1-5H3;4-9,11-12,14,16,34H,10,13H2,1-3H3;5-10,12-14,26H,11H2,1-4H3;4-9,11,13,15,17,32H,10,14H2,1-3H3;2*4-9,11-12,14,16,31H,10,13H2,1-3H3/t;16-;;17-;2*16-/m.1.111/s1 |
| InChIKey | APHIHXRWNBIOEW-RYJBLGHUSA-N |
| XLogP | 27.87 |
| TPSA | 482.83 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 193 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2606.48 |
| LogP ≤ 5 | 27.87 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 38 |